Shares of Vernalis plc (LON:VER) have been assigned an average recommendation of “Buy” from the five brokerages that are presently covering the stock. One investment analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 77.25 ($0.97).

Several brokerages have recently issued reports on VER. Panmure Gordon reiterated a “buy” rating and set a GBX 76 ($0.95) price target on shares of Vernalis plc in a research report on Thursday, September 22nd. Canaccord Genuity lifted their price target on Vernalis plc from GBX 84 ($1.05) to GBX 88 ($1.10) and gave the company a “buy” rating in a research report on Thursday, September 29th. Stifel Nicolaus lifted their price target on Vernalis plc from GBX 94 ($1.17) to GBX 99 ($1.24) and gave the company a “buy” rating in a research report on Tuesday, September 6th. Finally, N+1 Singer reiterated a “hold” rating and set a GBX 46 ($0.57) price target on shares of Vernalis plc in a research report on Thursday, September 29th.

ILLEGAL ACTIVITY NOTICE: “Vernalis plc (VER) Receives GBX 77.25 Consensus Price Target from Brokerages” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2016/11/28/vernalis-plc-ver-receives-gbx-77-25-consensus-price-target-from-brokerages.html.

In other news, insider David Mackney sold 27,233 shares of the firm’s stock in a transaction on Wednesday, October 12th. The stock was sold at an average price of GBX 39 ($0.49), for a total transaction of £10,620.87 ($13,269.45). Also, insider Carol Ferguson acquired 28,000 shares of Vernalis plc stock in a transaction dated Friday, September 30th. The shares were bought at an average cost of GBX 41 ($0.51) per share, with a total value of £11,480 ($14,342.83).

Vernalis plc (LON:VER) opened at 33.2865 on Wednesday. Vernalis plc has a 1-year low of GBX 31.00 and a 1-year high of GBX 72.75. The company has a 50-day moving average price of GBX 37.72 and a 200 day moving average price of GBX 41.97. The firm’s market capitalization is GBX 175.15 million.

Vernalis plc Company Profile

Vernalis plc is a commercial-stage pharmaceutical company. The Company is engaged in the research, development and commercialization of pharmaceutical products. The Company operates through two segments: Commercial, which covers all areas relating to the commercial sale of pharmaceutical products, the manufacture and distribution directly related to that activity, and Research and Development, which includes all activities related to the research and development of pharmaceutical products for a range of medical disorders.

Receive News & Stock Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vernalis plc and related stocks with our FREE daily email newsletter.